Current Edition

Cancer Research Center

Fred Hutch researchers tout Iclusig’s potential to tame cytokine storm in COVID but can’t get Takeda on board

Researchers at the Fred Hutchinson Cancer Research Center in Seattle say they have uncovered an FDA-approved drug that may be effective in combating the often-lethal …

Continue Reading →

After Moderna contamination mess, Takeda strikes deal with Japan to supply Novavax COVID-19 vaccines

As Moderna faces questions about contaminants found in its COVID-19 vaccines in Japan, the company’s distribution partner in the country, Takeda, is moving forward on …

Continue Reading →

TiGenix and Takeda announce Alofisel® (darvadstrocel) receives approval to treat complex perianal fistulas in Crohn’s disease in Europe

  First allogeneic stem cell therapy to receive central marketing authorization approval in Europe Alofisel offers a new treatment option for patients who do not …

Continue Reading →